MAXCYTE, INC.
A cell-engineering company with a platform for developing cell-based therapeutics.
MXCT | US
Overview
Corporate Details
- ISIN(s):
- US57777K1060 (+2 more)
- LEI:
- 54930053YHXULRFCU991
- Country:
- United States of America
- Address:
- 9713 KEY WEST AVENUE,, 20850 ROCKVILLE
- Website:
- https://www.maxcyte.com/
Description
MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-01-15 08:00 |
Trading Update
|
English | 30.7 KB | ||
| 2018-12-19 08:00 |
Change of Auditor
|
English | 17.0 KB | ||
| 2018-12-17 19:06 |
Director Dealings
|
English | 26.4 KB | ||
| 2018-11-21 08:00 |
Consolidation of Trading Lines
|
English | 19.6 KB | ||
| 2018-11-21 08:00 |
Consolidation of Trading Lines
|
English | 19.6 KB | ||
| 2018-11-20 08:00 |
Block Admission Six Monthly Return/TVR
|
English | 10.9 KB | ||
| 2018-11-20 08:00 |
Block Admission Six Monthly Return/TVR
|
English | 10.9 KB | ||
| 2018-11-16 08:00 |
Webinar: non-viral cell engineering
|
English | 19.6 KB | ||
| 2018-11-16 08:00 |
Webinar: non-viral cell engineering
|
English | 19.6 KB | ||
| 2018-11-14 08:00 |
Clinical and Commercial License Agreement
|
English | 19.9 KB | ||
| 2018-11-14 08:00 |
Clinical and Commercial License Agreement
|
English | 19.9 KB | ||
| 2018-11-12 08:00 |
MaxCyte Announces Research Agreement with Kite
|
English | 16.9 KB | ||
| 2018-11-12 08:00 |
MaxCyte Announces Research Agreement with Kite
|
English | 16.9 KB | ||
| 2018-11-09 08:00 |
Expansion of CRISPR Commercial License Agreement
|
English | 25.3 KB | ||
| 2018-11-09 08:00 |
Expansion of CRISPR Commercial License Agreement
|
English | 25.3 KB |
Automate Your Workflow. Get a real-time feed of all MAXCYTE, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MAXCYTE, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MAXCYTE, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
